Page last updated: 2024-10-27

fluoxetine and Movement Disorders

fluoxetine has been researched along with Movement Disorders in 9 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aragones, JM1
Blanch, CE1
Guillen-Font, A1
Escote-Llobet, S1
Rozzini, L1
Chilovi, BV1
Conti, M1
Bertoletti, E1
Zanetti, M1
Trabucchi, M1
Padovani, A1
Morelli, E1
Moore, H1
Rebello, TJ1
Gray, N1
Steele, K1
Esposito, E1
Gingrich, JA1
Ansorge, MS1
Creed, MC1
Hamani, C1
Bridgman, A1
Fletcher, PJ1
Nobrega, JN1
Chen, JJ1
Swope, DM1
Takahashi, T1
Kobayashi, T1
Ozaki, M1
Takamatsu, Y1
Ogai, Y1
Ohta, M1
Yamamoto, H1
Ikeda, K1
Connor, DF1
Benjamin, S1
Ozbayrak, KR1
Lauterbach, EC1
Shillcutt, SD1
Steiner, W1
Fontaine, R1

Other Studies

9 other studies available for fluoxetine and Movement Disorders

ArticleYear
[Buccolingual dyskinesia with justified hallucinations].
    Revista de neurologia, 2014, Nov-16, Volume: 59, Issue:10

    Topics: Alcoholism; Benzodiazepines; Clonazepam; Depressive Disorder; Dibenzothiazepines; Disulfiram; Female

2014
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.
    International psychogeriatrics, 2010, Volume: 22, Issue:1

    Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Citalopram; Cognition; Cognition Disorders; Depr

2010
Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Nov-02, Volume: 31, Issue:44

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Animals, Newborn; Basal Ganglia; Cell Count; C

2011
Contribution of decreased serotonin release to the antidyskinetic effects of deep brain stimulation in a rodent model of tardive dyskinesia: comparison of the subthalamic and entopeduncular nuclei.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Jul-11, Volume: 32, Issue:28

    Topics: 5,7-Dihydroxytryptamine; Amphetamines; Analysis of Variance; Animals; Antipsychotic Agents; Autoradi

2012
A case of complex movement disorder induced by fluoxetine with management of dystonia by botulinum toxin type A.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:2

    Topics: Aged; Anti-Dyskinesia Agents; Botulinum Toxins, Type A; Dyskinesia, Drug-Induced; Dystonic Disorders

2005
G protein-activated inwardly rectifying K+ channel inhibition and rescue of weaver mouse motor functions by antidepressants.
    Neuroscience research, 2006, Volume: 54, Issue:2

    Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tri

2006
Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:11

    Topics: Antipsychotic Agents; Dextroamphetamine; Diphenhydramine; Fluoxetine; Humans; Male; Mental Disorders

1995
Dyskinesia with fluoxetine: tardive or late-onset persistent, acute norfluoxetine dyskinesia?
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:2

    Topics: Acute Disease; Animals; Diagnosis, Differential; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Movem

1997
Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports.
    Biological psychiatry, 1986, Volume: 21, Issue:11

    Topics: Adult; Akathisia, Drug-Induced; Arrhythmias, Cardiac; Drug Interactions; Female; Fluoxetine; Humans;

1986